Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01439009
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01439009
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01439009. Randomized; quadruple masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2014-03 (actual). Results posted on 2019-10-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients
- Condition
- Heart Failure
- Intervention (Drug)
- Tolvaptan
- Intervention (Drug)
- Placebo of tolvaptan
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct01439009- Content hash
2330b29b7d42de85b12bf211dc04d1d6b78eb9575a90f8c295beb64ed3e3b322